Issued Patents 2022
Showing 1–7 of 7 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11426460 | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Peihong Dai, Weiyi Wang | 2022-08-30 |
| 11401335 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2022-08-02 |
| 11345755 | Anti-PD-1 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, Taha Merghoub, Roberta Zappasodi +4 more | 2022-05-31 |
| 11285209 | Recombinant MVA or MVAΔE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2022-03-29 |
| 11267889 | Anti-CTLA-4 antibodies and methods of use thereof | Marc van Dijk, Cornelia Anne Mundt, Gerd Ritter, David Schaer, Taha Merghoub +2 more | 2022-03-08 |
| 11253560 | Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors | Liang Deng, Taha Merghoub, Stewart Shuman, Peihong Dai, Weiyi Wang | 2022-02-22 |
| 11242509 | Vaccinia virus mutants useful for cancer immunotherapy | Liang Deng, Stewart Shuman, Ning-Sun Yang, Taha Merghoub | 2022-02-08 |